Related Experiment Video
Updated: Mar 17, 2026

CometChip: A High-throughput 96-Well Platform for Measuring DNA Damage in Microarrayed Human Cells
Published on: October 18, 2014
Cellular response to alkylating agent MNNG is impaired in STAT1-deficients cells
Laurent Ah-Koon1,2, Denis Lesage1,2, Elodie Lemadre1,2
1INSERM, U978, Bobigny, France.
Abstract:
The SN 1 alkylating agents activate the mismatch repair system leading to delayed G2 /M cell cycle arrest and DNA repair with subsequent survival or cell death. STAT1, an anti-proliferative and pro-apoptotic transcription factor is known to potentiate p53 and to affect DNA-damage cellular response. We studied whether STAT1 may modulate cell fate following activation of the mismatch repair system upon exposure to the alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Using STAT1-proficient or -deficient cell lines, we found that STAT1 is required for: (i) reduction in the extent of DNA lesions, (ii) rapid phosphorylation of T68-CHK2 and of S15-p53, (iii) progression through the G2 /M checkpoint and (iv) long-term survival following treatment with MNNG. Presence of STAT1 is critical for the formation of a p53-DNA complex comprising: STAT1, c-Abl and MLH1 following exposure to MNNG. Importantly, presence of STAT1 allows recruitment of c-Abl to p53-DNA complex and links c-Abl tyrosine kinase activity to MNNG-toxicity. Thus, our data highlight the important modulatory role of STAT1 in the signalling pathway activated by the mismatch repair system. This ability of STAT1 to favour resistance to MNNG indicates the targeting of STAT1 pathway as a therapeutic option for enhancing the efficacy of SN1 alkylating agent-based chemotherapy.
Insights
Signal transducer and activator of transcription 1 (STAT1) is crucial for cellular response to DNA damage from alkylating agents like MNNG. STAT1 promotes DNA repair and cell survival, suggesting it as a therapeutic target.
Area of Science:
- Molecular Biology
- Cellular Biology
- Cancer Research
Background:
- SN1 alkylating agents trigger the mismatch repair system, causing cell cycle arrest and DNA repair.
- Signal transducer and activator of transcription 1 (STAT1) is an anti-proliferative and pro-apoptotic factor influencing DNA damage response.
- STAT1 is known to enhance p53 activity and modulate cellular responses to DNA damage.
Purpose of the Study:
- To investigate the role of STAT1 in modulating cell fate after mismatch repair system activation by the alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
- To determine if STAT1 influences DNA repair, cell cycle progression, and survival following MNNG exposure.
Main Methods:
- Utilized STAT1-proficient and STAT1-deficient cell lines for comparative analysis.
- Assessed DNA lesion levels, phosphorylation of CHK2 and p53, G2/M checkpoint progression, and long-term cell survival after MNNG treatment.
- Investigated the composition of p53-DNA complexes, including STAT1, c-Abl, and MLH1, and the role of c-Abl tyrosine kinase activity.
Main Results:
- STAT1 is essential for reducing DNA lesions, rapid phosphorylation of T68-CHK2 and S15-p53, and G2/M checkpoint progression after MNNG exposure.
- STAT1 is required for long-term survival following MNNG treatment.
- STAT1 facilitates the formation of a p53-DNA complex with c-Abl and MLH1, linking c-Abl activity to MNNG-induced toxicity.
Conclusions:
- STAT1 plays a critical modulatory role in the signaling pathway activated by the mismatch repair system in response to MNNG.
- STAT1's ability to promote resistance to MNNG highlights the potential of targeting the STAT1 pathway to enhance chemotherapy efficacy.
- Targeting STAT1 may represent a therapeutic strategy to improve outcomes for patients treated with SN1 alkylating agents.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
Mitogens and the Cell Cycle
The JAK-STAT Signaling Pathway
The Intrinsic Apoptotic Pathway

